Stephen Ahenkorah

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability

G. Bormans, C. Deroose, T. Cardinaels, 2021, Frontiers in Medicine.

3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals

G. Bormans, Y. Seimbille, C. Deroose, 2022, Theranostics.

Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter

M. Koole, M. De Saint-Hubert, M. Ooms, 2022, EJNMMI Radiopharmacy and Chemistry.

Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors

F. Maxfield, T. Laitinen, R. Runyon, 2015, ChemMedChem.

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

G. Bormans, C. Deroose, T. Cardinaels, 2021, Pharmaceutics.

Antimalarial N 1,N 3-Dialkyldioxonaphthoimidazoliums: Synthesis, Biological Activity, and Structure-activity Relationships.

K. Tan, L. Birkholtz, S. Wittlin, 2019, ACS medicinal chemistry letters.

Loratadine analogues as MAGL inhibitors.

Tuomo Laitinen, T. Laitinen, J. Laitinen, 2015, Bioorganic & medicinal chemistry letters.